APA (7th ed.) Citation

RA, S., P, F., M, L., PJ, V., J, T., JS, T., . . . N, P. (2026). Asia-Pacific practical consensus in the management of adverse events related to amivantamab-based therapies in non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands), 216, 109405. https://doi.org/10.1016/j.lungcan.2026.109405

Chicago Style (17th ed.) Citation

RA, Soo, et al. "Asia-Pacific Practical Consensus in the Management of Adverse Events Related to Amivantamab-based Therapies in Non-small Cell Lung Cancer." Lung Cancer (Amsterdam, Netherlands) 216 (2026): 109405. https://doi.org/10.1016/j.lungcan.2026.109405.

MLA (9th ed.) Citation

RA, Soo, et al. "Asia-Pacific Practical Consensus in the Management of Adverse Events Related to Amivantamab-based Therapies in Non-small Cell Lung Cancer." Lung Cancer (Amsterdam, Netherlands), vol. 216, 2026, p. 109405, https://doi.org/10.1016/j.lungcan.2026.109405.